Fisher Scientific Group reported $4.3 million in net income and $220.1 million in revenue for the first quarter of 1987, its first quarter as a public company. Earlier this year, Henley Group Inc., which owns 80% of Fisher, distributed 20% of the health and scientific products company's stock to Henley shareholders.
Fisher had a pro forma loss of $220.6 million, including $159 million in restructuring charges, on $846 million in revenue for the year ended Dec. 31, 1986.
Sales of biomedical instruments used in laboratories and infusion systems that regulate and the administration of intravenous solutions to hospital patients were "particularly strong," according to Chairman Richard A. Cramer.
Fisher also reported that it has completed the sale of its 4.5% stake in Cambridge, Mass.-based Genetics Institute Inc.